Cancer is an invasive, adaptive process that interacts and adapts to the microenvironment, subjugating the normal tissue around it to optimise growth and survival.
moreAdrian Dunlop, Dr Amanda Brown, Dr Chris Dayas, A/Prof Peter Stanwell.
Mr Jamie Flynn, William Palmer, Antony Martin, Craig Gedye
Cancer is an invasive, adaptive process that interacts and adapts to the microenvironment, subjugating the normal tissue around it to optimise growth and survival.
moreConjoint Associate Professor Adrian Dunlop, Dr Amanda Brown, Dr Chris Dayas, Associate Professor Peter Stanwell.
The Greaves Family Early Career Support grant will ensure Dr Andrew Gardner from the Brain and Mental Health can continue to grow his research program in Sports Concusion continue to propel him forward as a nationally and internationally recognised concussion researcher.
moreSuzanne Snodgrass
Completing these projects successfully and on time will enable me to more effectively leverage for project funding in 2016.
moreMyopia (short-sightedness) is at epidemic levels across the world: in parts of Asia over 90% of young people are afflicted and in Australia and the USA the prevalence has doubled in recent years1.
moreDr Melissa Tadros, Professor Robert Callister
Motoneuron disease (MND) is an incurable illness that affects one’s ability to move and interact with the environment.
moreDr Michelle Kelly, Professor Skye McDonald, Dr Tracy Brown, Ms Katryna Harman
There are currently more than 342,000 people living with dementia in Australia, and an estimated 1.2 million people caring for them.
moreDr Rebecca Lim, Professor Alan Brichta, Professor Robert Callister, Dr Doug Smith
Hearing and balance problems arise due to ageing, environmental assaults, medications, disease, and genetic disorders.
moreAssociate Professor Frederick Rohan Walker, Dr Lin Ong, Dr Ming Yang, Associate Professor Sarah Johnson
It has recently been recognised that many stroke patients can experience what is known as ‘chronic phase decline” associated with gradual, but very significant, declines in both motor and cognitive function.
moreDr Saad Ramadan, Associate Professor Jeannette Lechner-Scott
Magnetic resonance imaging is not only important in the diagnosis of multiple sclerosis but also to monitor therapy.
moreDr Vicki Maltby, Associate Professor Jeannette Lechner-Scott, Dr Rodney Lea
Multiple Sclerosis (MS) is the most common non-traumatic neurological disorder that affects young adults.
moreMs Ashlee Dunn
Dr Jamie Flynn, Anthony Martin, William Palmer
The CLARITY Microscope is a new technology that enables 3D imaging of tissues. It has caught the imagination and attention of one of our major donors who granted $150,000 to build a microscope here at HMRI as a shared service.
moreMr Joshua Atkins, Associate Professor Murray Cairns, Dr Chantel Fitzsimmons
Schizophrenia and related psychotic disorders are among the world’s most debilitating brain diseases.
moreAssociate Professor Neil Spratt, Damian McLeod, Lucy Murtha, Daniel Beard
Funding will be used to conduct preliminary studies of the effects of increased brain pressure (intracranial pressure) on blood flow after stroke.
moreC A/Prof Jeannette Lechner-Scott, Katherine Sanders, Rebecca Seeto
MS is a chronic, life-long, disease which has no cure.
moreDr Neil Spratt, Dr Damien McLeod
Ischaemic stroke, caused by blood clot blocking an artery to the brain, is a leading cause of death and disability.
moreCancer is one of the leading causes of death worldwide. Brain cancer is the 15th most common cancer in the world, and has one of the worst survival rates of all cancer types, with only approximately half of patients surviving for one year post-diagnosis. This poor survival rate highlights that new treatments for brain cancer are urgently required.
moreDr James Lynam, Jennette Sakoff, Jenny Martin, Lisa Lincz, Mike Fay, Giovana Celli Marchett, Peter Galettis
Annually there are 2,000 new cases of brain cancer in Australia. Prognosis for people with brain cancer is dire. It is the highest cause of death in 0-39 age group with a 5-year survival rate of 19%. Brain cancer results in 5,000 hospitalisations per year (average stay 12.5 days, the longest of any cancer) and has the highest lifetime cost per patient of $1.89m.
moreProfessor Hubert Hondermarck, Phil Jobling, Marjorie Walker, Janine Lombard, Jay Pundavela, Sam Faulkner
A new paradigm shift in oncology has revealed the role of nerves in cancer initiation and progression.
moreDr Nikola Bowden, Dr Jim Scurry, Dr Geoff Otton, Dr Ken Jaaback, Dr Janine Lombard
To develop a test for predicting ovarian cancer response/resistance to cisplatin chemotherapy that can be quickly implemented in clincial centres.
moreMrs Susan Goode, Chloe Warren
Dr Kathryn Skelding, Dr Mengna Chi, Dr Nicole Verrills, Dr Roger Liang
Acute myeloid leukaemia (AML) is the most common acute leukaemia affecting adults, and accounts for ~20% of childhood leukaemias.
moreAustralia has the highest incidence of melanoma in the world and kills more young Australians aged 20–34 years old than any other single cancer.
moreDr Helen Wheeler, Dr Viive Howell, Associate Professor Michael Back and Professor Stephen Ackland
While a diagnosis of a brain tumour is devastating and life-changing, low grade brain tumours initially have a relatively slow moving clinical course and good prognosis.
moreMs Marina Kastelan
I would propose to attend the 20th Annual Society for Neuro-Oncology Annual Scientific Meeting and Education Day November 19-22, 2015 - San Antonio Marriott Rivercenter, San Antonio, Texas.
moreDr Craig Gedye will use his Mark Hughes Foundation Travel Grant to join top national and international researchers at the COGNO (Co-operative Trials Group for Neuro-Oncology) meeting in Brisbane.
moreDr Mike Fay
Dr Mike Fay is a Calvary Mater Newcastle radiation oncologist and used his Mark Hughes Foundation Travel Grant to attend the ‘Technology meets patient care’ American Society for Therapeutic Radiation Oncology (ASTRO) meeting in San Antonio, Texas, from October 18-21. This grant will help Mike in his goal to develop better brain tumour imaging and therapeutics.
moreDr Viive Howell
Funding is requested to attend the Inaugural International Cancer Immunotherapy Conference, September 16 -19, 2015, in New York, New York, USA.
moreDr Adrian Lee
Dr Adrian Lee is also attending Dr Lee the COGNO Annual Scientific Meeting in Brisbane this month to present data on the use of the drug Bevacizumab in Glioma (a tumour that begins in the brain’s glial cells).
moreDr Pia Laegdsgaard, Ms Demi Lund
Pia Laegdsgaard will use her Mark Hughes Foundation travel grant to present at the COGNO Annual Scientific Meeting in Brisbane this month. Pia has developed a research poster outlining the processes involved in establishing and managing the brain cancer facility as part of the HCB.
moreCancer is the leading cause of death in Australia. Each year over 120,000 Australian’s will be diagnosed with cancer, and tragically, more than 42,000 patients will die from this disease.
moreOvarian cancer is usually treated with a chemotherapy drug called cisplatin which works by damaging DNA so much that the tumour cells die.
moreThe Greaves Family Early Career Support grant will enure Myles Young can extend his research with the SHED-IT weight loss program to achieve his goal of becoming an independent and internationally reputable early career researcher in the Hunter Region.
moreProfessor Anthony Quail, Associate Professor David Cottee
Dopamine and droperidol are drugs used in modern anaesthetic practice. Both drugs are known to modulate carotid body function via an action on dopamine type-2 receptors.
moreDr Vivienne Chuter, Ms Peta Craike
Diabetes is associated with significant risk of disease of both the large and small blood vessels.
moreMs Kristine Pezdirc
Funding to IMCAS is devoted to education in the field of cosmetic dermatology, cosmetic surgery and cosmeceuticals.
moreMs Lisa Spencer, Professor Clare Collins, Dr Megan Rollo, Dr Melinda Hutchesson
The aim of my PhD is to investigate effective and innovative approaches to managing weight during pregnancy and following childbirth.
moreAssociate Professor Anthony Quail, Associate Professor David Cottee
Many commonly used anaesthetic drugs alter respiratory and cardiovascular control mechanisms, interfering with the life-preserving homeostatic reflexes.
moreKirsty will use The Equal Futures funding to attend the 2016 National Higher Education Women Leadership Summit in Melbourne 2016.
morePremature ovarian failure (POF) is the early loss of ovarian function before age 40.
moreAssociate Professor Bruce King
Dr Gemma Masden, Dr Sharyn Rayner
Preterm birth is the leading cause of neonatal death and sickness and so the prevention of preterm labour is one of the major goals in obstetrics.
moreProfessor Chris Doran, Dr Rod Ling
Suicidal behaviour has gained recognition worldwide as a significant public health problem.
morePreterm birth continues to be a major health problem throughout the world.
moreThe charitable purpose of this grant is to deliver liposomes, coated with an antibody that recognizes the oxytocin receptor (OTR), directly to the muscle of the uterus.
morePremature birth is the most common reason for a newborn baby to die. Unfortunately, current treatments for premature birth are not very effective.
moreMs Megan Patterson, Associate Professor Bruce King, Dr Carmel Smart, Dr Prudence Lopez
Funding to support the Gomeroi gaaynggal Community ArtsHealth running in Tamworth - covers art consumables which brings participants into the centre to participate in health screening and research being conducted.
moreGlobally, nearly 1% of all pregnancies end in stillbirth (3 million each year). The magnitude and gravity of stillbirth is such that in 2011 an entire Lancet series was devoted to it and urged a strong call to action, concluding that greater knowledge of causes is a key health priority. In Australia, stillbirth accounts for around 70% of all perinatal deaths (7 deaths per day) and is nearly 40 times more common than Sudden Infant Death Syndrome. Existing knowledge has had no impact on reducing the stillbirth rate, and a 2013 BMJ review of the UK data on stillbirth concluded "preventive strategies need to focus on improving antenatal detection".
moreLaureate Professor Robert Sanson-Fisher, Dr Mariko Carey, Dr Elise Mansfield, Dr Chris Oldmeadow, Ms Natalie Dodd
Despite innovative programs to increase colorectal cancer (CRC) screening amongst people >50 years of age, such the National Bowel Cancer Screening Program (NBCSP), current screening rates are low.
moreDr Craig Dalton
Nicole Byrne
Nicole will use the Equal Futures grant funding for individual academic writing coaching for publication and grant applications to enable her to achieve her goal of moving from a clinical role to an academic role in speech pathology research.
Gillian will use her Equal Futures funding for 3-4 one-on-one sessions with an external professional mentor and also to travel to New Zealand to build and strengthen her collaborations with Maori researchers to enable Gillian to reach her goal of being a national and international leader in Indigenous Health research.
Professor Chris Doran, Dr Rod Ling
Most deaths by suicide are among young people.
moreTravel support for Dr Yoong to attend & participate in the 2015 Training Institute for Dissemination and Implementation Research in Health (TIDIRH) supported by the National Institutes of Health and the U.S. Department of Veterans Affairs, July 26-31, 2015.
moreMr James Pinkerton, Jay Horvat, Phil Hansbro
The Greaves Family Postgraduate Scholarship in Medical Research will allow James Pinkerton to complete his PhD studies to understand the mechanisms that underpin steroid-resistant asthma.
moreDr Joshua Davis, Associate Professor Michael Boyle
Blood stream infection caused by bacteria known as ESCaPMs (an acronum standing for their names: Enterobacter, Serratia, Citrobacter, Providencia and Morganella) is common and promlematic, with over 45 cases at JHH annually.
moreDr Hock Tay, Dr Maximilian Plank, Dr Steven Maltby, Laureate Professor Paul Foster
Cystic fibrosis (CF) is a genetic disorder that affects 1 in 2,500 people born in Australia.
moreAround 10% of the Australian population sufffer from Asthama. Current therapies prevent only ~40% of asthma exacerbations.
moreAsthma is the most common chronic childhood disease, affecting 10% of Australian children.
moreSmoking leads to lung inflammation that causes emphysema - a major health problem in Australia.
moreCurrently infants from the BLT cohort will be followed-up at birth, 6 weeks of age and 12 months of age.
more